DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association

Media coverage

• Title	DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association
  Media name/outlet	Thomson Reuters One
  Country/Territory	United States
  Date	22/02/19
  Persons	Kurt Hirschhorn

• Title	DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association
  Media name/outlet	PrimeNewswire (XML)
  Country/Territory	United States
  Date	22/02/19
  Persons	Kurt Hirschhorn